Should You Think About Buying Paragon Care Limited (ASX:PGC) Now?




  • In Business
  • 2023-01-25 02:12:51Z
  • By Simply Wall St.
 

Paragon Care Limited (ASX:PGC), is not the largest company out there, but it saw a decent share price growth in the teens level on the ASX over the last few months. As a small cap stock, hardly covered by any analysts, there is generally more of an opportunity for mispricing as there is less activity to push the stock closer to fair value. Is there still an opportunity here to buy? Let's examine Paragon Care's valuation and outlook in more detail to determine if there's still a bargain opportunity.

Check out our latest analysis for Paragon Care

What Is Paragon Care Worth?

Paragon Care is currently expensive based on my price multiple model, where I look at the company's price-to-earnings ratio in comparison to the industry average. In this instance, I've used the price-to-earnings (PE) ratio given that there is not enough information to reliably forecast the stock's cash flows. I find that Paragon Care's ratio of 30.74x is above its peer average of 23.91x, which suggests the stock is trading at a higher price compared to the Healthcare industry. But, is there another opportunity to buy low in the future? Since Paragon Care's share price is quite volatile, this could mean it can sink lower (or rise even further) in the future, giving us another chance to invest. This is based on its high beta, which is a good indicator for how much the stock moves relative to the rest of the market.

What kind of growth will Paragon Care generate?

Future outlook is an important aspect when you're looking at buying a stock, especially if you are an investor looking for growth in your portfolio. Buying a great company with a robust outlook at a cheap price is always a good investment, so let's also take a look at the company's future expectations. With profit expected to more than double over the next couple of years, the future seems bright for Paragon Care. It looks like higher cash flow is on the cards for the stock, which should feed into a higher share valuation.

What This Means For You

Are you a shareholder? PGC's optimistic future growth appears to have been factored into the current share price, with shares trading above industry price multiples. At this current price, shareholders may be asking a different question - should I sell? If you believe PGC should trade below its current price, selling high and buying it back up again when its price falls towards the industry PE ratio can be profitable. But before you make this decision, take a look at whether its fundamentals have changed.

Are you a potential investor? If you've been keeping tabs on PGC for some time, now may not be the best time to enter into the stock. The price has surpassed its industry peers, which means it is likely that there is no more upside from mispricing. However, the positive outlook is encouraging for PGC, which means it's worth diving deeper into other factors in order to take advantage of the next price drop.

So if you'd like to dive deeper into this stock, it's crucial to consider any risks it's facing. For example, we've found that Paragon Care has 3 warning signs (1 makes us a bit uncomfortable!) that deserve your attention before going any further with your analysis.

If you are no longer interested in Paragon Care, you can use our free platform to see our list of over 50 other stocks with a high growth potential.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Join A Paid User Research Session
You'll receive a US$30 Amazon Gift card for 1 hour of your time while helping us build better investing tools for the individual investors like yourself. Sign up here

COMMENTS

More Related News

Transaction Capital Limited
Transaction Capital Limited's (JSE:TCP) Shares May Have Run Too Fast Too Soon

Transaction Capital Limited's ( JSE:TCP ) price-to-earnings (or "P/E") ratio of 16.1x might make it look like a strong...

Investors in My Food Bag Group (NZSE:MFB) have unfortunately lost 62% over the last year
Investors in My Food Bag Group (NZSE:MFB) have unfortunately lost 62% over the last year

The nature of investing is that you win some, and you lose some. And there's no doubt that My Food Bag Group Limited...

Investors in Auswide Bank (ASX:ABA) have unfortunately lost 7.9% over the last year
Investors in Auswide Bank (ASX:ABA) have unfortunately lost 7.9% over the last year

Investors can approximate the average market return by buying an index fund. Active investors aim to buy stocks that...

Investors in Revenue Group Berhad (KLSE:REVENUE) have unfortunately lost 63% over the last year
Investors in Revenue Group Berhad (KLSE:REVENUE) have unfortunately lost 63% over the last year

Revenue Group Berhad ( KLSE:REVENUE ) shareholders should be happy to see the share price up 13% in the last month. But...

Those who invested in AVITA Medical (ASX:AVH) five years ago are up 147%
Those who invested in AVITA Medical (ASX:AVH) five years ago are up 147%

When you buy shares in a company, it's worth keeping in mind the possibility that it could fail, and you could lose...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business